India Insights April 2026

The April 2026 report highlights a sharp 9.17% rebound in Indian equities and identifies the BJP's West Bengal election victory as a major long-term growth catalyst. It maintains a bullish stance on industrials, financials, and healthcare, particularly emphasizing the new market for generic GLP-1 weight-loss drugs.

Key Takeaways

• 1.The Indian equity market rebounded sharply in April with the MSCI India Index returning 9.17%, driven by a ceasefire in the Middle East and cooling oil prices.
• 2.The BJP's victory in West Bengal is viewed as a structural catalyst that will pivot the state toward infrastructure-led development, similar to the transformation seen in Uttar Pradesh.
• 3.AI is causing disruption and headcount rationalization in urban IT hubs, but productivity gains are fueling expansion into tier-2 and tier-3 cities.

Table of Contents

• Market Review
• Portfolio Commentary & Outlook
• The March Drawdown and April Rebound: Conviction Tested, Conviction Rewarded
• West Bengal: A Structural Floor for India's Growth Story
• AI Disruption: Pain in the Metros, Opportunity in the Hinterland
• Portfolio Positioning
• Tidbits from the Ground
• Semaglutide Goes Generic: A Defining Shift in the GLP-1 Opportunity
• Health and Wellness Emerging as a Major Consumer Trend

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial